# LB Pharmaceuticals Inc Common Stock (LBRX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/LBRX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -70.66M | $ -61.31M | $ 5.22M | $ 332.35M |
| 2025 | $ 0 | $ -25.81M | $ -36.10M | $ 3.57M | $ 301.31M |
| 2024 | $ 0 | $ -61.00M | $ -50.37M | $ 0 | $ -50.45M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.02 |
| Liabilities / Eq | 0.09 |
| Current Ratio | 15.08 |

## Other views

- [Metrics](https://sponda.capital/en/LBRX.md)
- [Charts](https://sponda.capital/en/LBRX/charts.md)
- [Compare](https://sponda.capital/en/LBRX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.